Email ID
Password
Sign me in automatically next time
clinica
RECENT TWEETS    
01 September 2014

 
01 September 2014
As the traditional summer holiday period comes to an end in Europe and medtech executives and return to their office desks, the biggest thing on their minds will be how the future new regulations on medical devices and IVDs will change their way of ...
29 August 2014
Japan has announced ambitious new plans to speed up the development and evaluation of locally developed innovative pharmaceuticals, medical devices and regenerative medicines. The plans feed into Japan's aims to establish the country as the world ...
29 August 2014
The trend for big technology companies getting increasingly involved in the medical device arena isn’t going away anytime soon, and it could have a big impact on the sector. “I think it’s going to change the industry significantly in years to come,” ...
28 August 2014
The last three months have seen a flurry of M&A activity and as summer starts drawing to a close, it looks like the medtech players are rushing to bag some end-of-season deals. Covidien’s appetite for bolt-on acquisitions has not waned. Just under ...
 
29 August 2014
Japan has announced ambitious new plans to speed up the development and evaluation of locally developed innovative pharmaceuticals, medical devices and regenerative medicines. The plans feed into Japan's aims to establish the country as the world ...
29 August 2014
With the European Society of Cardiology’s (ESC’s) annual meeting starting on 30 August in Barcelona, Spain, Clinica takes a look at some of the key developments expected at the meeting. Vagus nerve stimulation (VNS) for heart failure is set to be a ...
29 August 2014
The trend for big technology companies getting increasingly involved in the medical device arena isn’t going away anytime soon, and it could have a big impact on the sector. “I think it’s going to change the industry significantly in years to come,” ...
29 August 2014
The summer M&A flurry is showing no sign of slowing as August comes to a close: the latest deal, in diagnostics, sees Germany’s Orgentec Diagnostika acquiring Corgenix Medical for $0.27 per share or around $16m in total. Denver, Colorado-based ...
 
29 August 2014
The trend for big technology companies getting increasingly involved in the medical device arena isn’t going away anytime soon, and it could have a big impact on the sector. “I think it’s going to change the industry significantly in years to come,” ...
29 August 2014
The summer M&A flurry is showing no sign of slowing as August comes to a close: the latest deal, in diagnostics, sees Germany’s Orgentec Diagnostika acquiring Corgenix Medical for $0.27 per share or around $16m in total. Denver, Colorado-based ...
28 August 2014
The last three months have seen a flurry of M&A activity and as summer starts drawing to a close, it looks like the medtech players are rushing to bag some end-of-season deals. Covidien’s appetite for bolt-on acquisitions has not waned. Just under ...
28 August 2014
Californian company NeuroSigma has filed for a $50m initial public offering to fund development of its Monarch external trigeminal nerve stimulation system (eTNS) system for epilepsy and depression. The firm, which plans to trade on the Nasdaq under ...
 
01 September 2014
The US National Institutes of Health issued a final policy about sharing genomic data, which will apply to all federal government-funded large-scale human and non-human projects that generate such information, including research conducted with the ...
01 September 2014
As the traditional summer holiday period comes to an end in Europe and medtech executives and return to their office desks, the biggest thing on their minds will be how the future new regulations on medical devices and IVDs will change their way of ...
29 August 2014
Japan has announced ambitious new plans to speed up the development and evaluation of locally developed innovative pharmaceuticals, medical devices and regenerative medicines. The plans feed into Japan's aims to establish the country as the world ...
28 August 2014
With under a month before US requirements on unique device identification (UDI) come into force, the FDA has issued a Q&A document that addresses questions it frequently receives on the topic. The document summarizes key aspects of the UDI ...
 
Ex-Edwards exec Stefan Schreck becomes JenaValve CTO Not long after bagging a new CEO, German transcatheter aortic valve developer JenaValve has appointed Stefan Schreck chief technology officer. Dr ...
Former SNN exec to head up Rex Bionics Robotic exoskeleton developer Rex Bionics has appointed Crispin Simon CEO; when Mr Simon joins in October 2014, current chief Jeremy Curnock Cook ...
CryoLife makes Medtronic executive Mackin CEO CryoLife, which specializes in providing preserved human cardiac and vascular tissues for surgery, has appointed James Patrick (Pat) Mackin president ...
22 August 2014
Ashley Yeo

The case for a more concerted move towards adoption of digital pathology is stronger than ever. That is the impression left by Sara Dalmasso , GE Healthcare ’s UK-based general manager for digital pathology Europe, who says that the cost, accuracy ...

18 August 2014
Amanda Maxwell

News that the Australian Therapeutic Goods Administration is to re-audit all medical devices in Australia that were previously assessed by a group of eight specific notified bodies could represent a global challenge to the integrity of the current ...

 
27 August 2014
Madeleine Armstrong

Would you want to know if you had an incurable disease like Alzheimer’s? According to a survey funded by GE Healthcare, 74% of people worldwide would want the bad news, even if the treatment options are limited. The results, from 10,000 people in ...

22 August 2014
Ashley Yeo

The case for a more concerted move towards adoption of digital pathology is stronger than ever. That is the impression left by Sara Dalmasso , GE Healthcare ’s UK-based general manager for digital pathology Europe, who says that the cost, accuracy ...

21 August 2014
Tina Tan

Ideas remain only ideas, no matter how good, unless they are nurtured in the right environment and developed into commercializable products. Helping to transform promising medical inventions emerging from Israel – one of the world’s technology ...

 
27 August 2014
Madeleine Armstrong

Would you want to know if you had an incurable disease like Alzheimer’s? According to a survey funded by GE Healthcare, 74% of people worldwide would want the bad news, even if the treatment options are limited. The results, from 10,000 people in ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

21 May 2014
Amanda Maxwell

There is a perceptible buzz these days around the subjects o fmHealth and healthcare apps. But how fast is the technology in these areas changing? How are the regulators going to police this market when it starts to really take off? Amanda Maxwell ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
05 August 2014

Specialty area(s): Alzheimer’s disease diagnostics Based in: Sacramento, California, US Founded in: 2010 No. of employees: 10 Total investment received to date: Around $4.5m Investors: Undisclosed

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
 
© 2014 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36